Mads Ravnborg - Concepedia

Author

Mads Ravnborg

Also Known As

BATTAGLIA, MARIO ALBERTO, Eugene O Major, M Ravnborg, M. H. Ravnborg, M. RAVNBORG, M. Ravnborg, M.H. Ravnborg, Mads H Ravnborg, Mads H. Ravnborg, Mads Henrik Ravnborg

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Copenhagen University Hospital Danish Multiple Sclerosis Center Odense University Hospital University of Copenhagen

About

Mads Ravnborg is an author at Rigshospitalet specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	2.7K
2	Health Sciences	7	7	1.1K
3	Social Sciences	4	4	233
4	Applied Physiology	3	3	194
5	Anesthesia	2	2	49

Mads Ravnborg

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial Vittorio Martinelli, M. Rodegher, Lucia Moiola, The Lancet Neurological DisorderMedicineClinical NeurologyClinical TrialsPrecise Study	2009	585
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis Per Soelberg Sørensen, Katja Maria Clemmesen, Klaus Bendtzen, The Lancet Clinical ImmunologyRelapsing-remitting Multiple SclerosisAutoimmune DiseaseClinical ImportanceImmunodeficiencies	2003	371
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension Raju Kapoor, Pei‐Ran Ho, Nolan Campbell, The Lancet Neurology Disease ProgressionNeurological DisorderImmunologyClinical TrialsNeurology	2018	327
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring Ludwig Kappos, David O. Bates, Gilles Edan, The Lancet Neurology Translational MedicineSystemic SclerodermaMedicineImmunologyClinical Trials	2011	265
Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis B. Wanscher, C.V. Jensen, Karen Schreiber, Neurology Neurological DisorderImmunologyClinical NeurologyBrain LesionImmunotherapy	1998	239
Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS Morten Blinkenberg, Karina Rune, C.V. Jensen, Neurology	2000	149
Post-activation depression of Soleus stretch reflexes in healthy and spastic humans Michael J. Grey, Klaus Klinge, Clarissa Crone, Experimental Brain Research Post-activation DepressionPain SyndromeMuscle FunctionPhysiologyPeripheral Nervous System	2007	139
Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients Per Soelberg Sørensen, Nils Koch‐Henriksen, Thor Petersen, Journal of Neurology Natalizumab TherapyDisease ProgressionClinical RelapsesMedicineMetronomic Therapy	2014	138
The Six Spot Step Test: a new measurement for walking ability in multiple sclerosis Magdalena M. Nieuwenhuis, Hans van Tongeren, Per Soelberg Sørensen, Multiple Sclerosis Journal	2006	135
Immunoglobulin Treatment Versus Plasma Exchange in Patients with Chronic Moderate to Severe Myasthenia Gravis Jesper Rønager, Mads Ravnborg, I Hermansen, Artificial Organs	2001	132

Page 1